{"id":2289,"date":"2019-12-31T19:32:06","date_gmt":"2019-12-31T18:32:06","guid":{"rendered":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/"},"modified":"2019-12-31T19:32:06","modified_gmt":"2019-12-31T18:32:06","slug":"la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable","status":"publish","type":"post","link":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/","title":{"rendered":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable."},"content":{"rendered":"<p><strong>2019<\/strong><\/p>\n<p><em>Xavier Causse, H\u00e9l\u00e8ne Labadie, Jean-Fran\u00e7ois Cadranel, Gilles Macaigne, Hatem Salloum, Anne-Marie Roque-Afonso, pour les investigateurs de l\u2019ANGH et du CREGG<\/em><\/p>\n<p><strong>H\u00e9patologie <\/strong>&#8211; \u00a02019-05-17 &#8211;\u00a0CO &#8211;<\/p>\n<p>________________________________<\/p>\n<p>Introduction :<br \/>\nParmi 665 porteurs inactifs de l\u2019AgHBs pr\u00e9-s\u00e9lectionn\u00e9s, 594 ont \u00e9t\u00e9 inclus de septembre 2014 \u00e0 juin 2016. Les premiers ach\u00e8veront leur suivi en septembre 2019, les derniers en juin 2021.<br \/>\nPatients et M\u00e9thodes :<br \/>\n427 suivis sont complets \u00e0 1 an, 367 \u00e0 2 ans, 279 \u00e0 3 ans, 82 \u00e0 4 ans.<br \/>\nR\u00e9sultats :<br \/>\n5 s\u00e9roconversions anti-HBs ont \u00e9t\u00e9 observ\u00e9es \u00e0 1 an, 7 la deuxi\u00e8me ann\u00e9e, 11 la troisi\u00e8me ann\u00e9e, 1 la quatri\u00e8me, soit 24 au total \u00e0 ce jour. 5 patients ont \u00e9t\u00e9 mis sous t\u00e9nofovir ou ent\u00e9cavir la premi\u00e8re ann\u00e9e, 2 fois pour un motif pr\u00e9emptif ; 7 la seconde ann\u00e9e, 2 fois pour un motif pr\u00e9emptif ; 3 la troisi\u00e8me ann\u00e9e, dont 1 pour motif pr\u00e9emptif ; donc \u00e0 ce jour 15 d\u00e9buts de traitement, dont 5 pour un motif pr\u00e9emptif. Il n\u2019a \u00e9t\u00e9 observ\u00e9 aucun \u00e9v\u00e9nement d\u00e9favorable : pas de carcinome h\u00e9pato-cellulaire, pas de cirrhose, pas d\u2019insuffisance h\u00e9patique, pas de d\u00e9c\u00e8s.<br \/>\nConclusion :<br \/>\nCette \u00e9tape interm\u00e9diaire de surveillance des patients inclus dans PIBAC confirme le bon pronostic de ces patients. Les s\u00e9roconversions anti-HBs (24) sont plus nombreuses que les initiations de traitement (15), dont certaines l\u2019ont \u00e9t\u00e9 pour un motif pr\u00e9emptif (5). Il est n\u00e9cessaire de poursuivre un recueil optimal des donn\u00e9es de surveillance de ces patients pour permettre l\u2019analyse des facteurs pronostiques de ces \u00e9v\u00e8nements.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2019 Xavier Causse, H\u00e9l\u00e8ne Labadie, Jean-Fran\u00e7ois Cadranel, Gilles Macaigne, Hatem Salloum, Anne-Marie Roque-Afonso, pour les investigateurs de l\u2019ANGH et du CREGG H\u00e9patologie &#8211; \u00a02019-05-17 &#8211;\u00a0CO &#8211; ________________________________ Introduction : Parmi 665 porteurs inactifs de l\u2019AgHBs pr\u00e9-s\u00e9lectionn\u00e9s, 594 ont \u00e9t\u00e9 inclus de septembre 2014 \u00e0 juin 2016. Les premiers ach\u00e8veront leur suivi en septembre 2019, les [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[30],"class_list":["post-2289","post","type-post","status-publish","format-standard","hentry","category-hepatologie","tag-30"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH<\/title>\n<meta name=\"description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"og:description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\" \/>\n<meta property=\"og:site_name\" content=\"Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-31T18:32:06+00:00\" \/>\n<meta name=\"author\" content=\"Bruno Lesgourgues\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bruno Lesgourgues\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\"},\"author\":{\"name\":\"Bruno Lesgourgues\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/d70d83701c6dda5f93e12e8bafca7d7d\"},\"headline\":\"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable.\",\"datePublished\":\"2019-12-31T18:32:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\"},\"wordCount\":270,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"keywords\":[\"2019\"],\"articleSection\":[\"Hepatologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\",\"url\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\",\"name\":\"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#website\"},\"datePublished\":\"2019-12-31T18:32:06+00:00\",\"description\":\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\",\"breadcrumb\":{\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/angh.net\/abstracts\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/angh.net\/abstracts\/#website\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"name\":\"Abstracts des congr\u00e8s de l&#039;ANGH\",\"description\":\"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003\",\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/angh.net\/abstracts\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\",\"name\":\"ANGH\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"contentUrl\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"width\":48,\"height\":18,\"caption\":\"ANGH\"},\"image\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/d70d83701c6dda5f93e12e8bafca7d7d\",\"name\":\"Bruno Lesgourgues\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g\",\"caption\":\"Bruno Lesgourgues\"},\"url\":\"https:\/\/angh.net\/abstracts\/author\/blesgourgues-2\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/","og_locale":"fr_FR","og_type":"article","og_title":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH","og_description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","og_url":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/","og_site_name":"Abstracts des congr\u00e8s de l&#039;ANGH","article_publisher":"https:\/\/www.facebook.com\/ANGH-2136322560030484\/","article_published_time":"2019-12-31T18:32:06+00:00","author":"Bruno Lesgourgues","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Bruno Lesgourgues","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#article","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/"},"author":{"name":"Bruno Lesgourgues","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/d70d83701c6dda5f93e12e8bafca7d7d"},"headline":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable.","datePublished":"2019-12-31T18:32:06+00:00","mainEntityOfPage":{"@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/"},"wordCount":270,"commentCount":0,"publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"keywords":["2019"],"articleSection":["Hepatologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/","url":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/","name":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable. - Abstracts des congr\u00e8s de l&#039;ANGH","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/#website"},"datePublished":"2019-12-31T18:32:06+00:00","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","breadcrumb":{"@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/angh.net\/abstracts\/la-surveillance-des-porteurs-inactifs-de-lantigene-hbs-inclus-dans-la-cohorte-pibac-confirme-leur-pronostic-favorable\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/angh.net\/abstracts\/"},{"@type":"ListItem","position":2,"name":"La surveillance des porteurs \u00bbinactifs \u00bb de l\u2019antig\u00e8ne HBs inclus dans la cohorte PIBAC confirme leur pronostic favorable."}]},{"@type":"WebSite","@id":"https:\/\/angh.net\/abstracts\/#website","url":"https:\/\/angh.net\/abstracts\/","name":"Abstracts des congr\u00e8s de l&#039;ANGH","description":"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003","publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angh.net\/abstracts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/angh.net\/abstracts\/#organization","name":"ANGH","url":"https:\/\/angh.net\/abstracts\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/","url":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","contentUrl":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","width":48,"height":18,"caption":"ANGH"},"image":{"@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ANGH-2136322560030484\/"]},{"@type":"Person","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/d70d83701c6dda5f93e12e8bafca7d7d","name":"Bruno Lesgourgues","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5c737979cf1cff53a280fef17e77a5e495d143e87a53eee6fcc0b272bb973c75?s=96&d=mm&r=g","caption":"Bruno Lesgourgues"},"url":"https:\/\/angh.net\/abstracts\/author\/blesgourgues-2\/"}]}},"_links":{"self":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/comments?post=2289"}],"version-history":[{"count":0,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2289\/revisions"}],"wp:attachment":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/media?parent=2289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/categories?post=2289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/tags?post=2289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}